tirzepatide nafld Effect of versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 Tirzepatide in metabolic dysfunction-associated steatotic
Description
However, in some cases, a medical professional may consider administering the drug in order to monitor the patient

10.1038/s42255-024-01061-4 38 KnerrP

After removing duplicate entries, a total of 57 DM2 DMTs were collected

MMRM was used in primary efficacy analysis, and it assumes that data are MAR

Hoover, 2017
